A binding-to-release strategy for targeted anticancer drug delivery.
A framework that overcomes the internalization barrier, broadening the target scope for therapeutic and diagnostic conjugates is established and extended BTR to programmed cell death ligand 1 (PD-L1) and an mRNA-display-derived FAP peptide, suggesting potential broad applicability.
Zihao Wen, Mengxin Xu, Zi-Jun Yan et al.
· Nature · 1 citation